Bioengineered Corneal Stroma Scaffold Alignment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods struggle to create a three-dimensional orderly collagen-fibril construct for tissue engineering, particularly in the corneal stroma, as keratocytes lose their phenotype when cultured in serum-based media, leading to scar tissue formation, and there is a need for biodegradable scaffolds that mimic native tissue properties.

Innovation Solution

The development of biodegradable scaffolds with aligned fibers, produced using electrospinning techniques, where keratocytes are cultured to produce an extracellular matrix that replaces the scaffold, and stem cells are differentiated into functional keratocytes to create a bioscaffold for corneal implantation, which can be decellularized and populated with native cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If keratocytes are cultured in serum-based media to expand cell population, then cell quantity increases, but keratocytes lose their phenotype and differentiate into fibroblasts, leading to scar tissue formation

Engineering Contradiction:
Improvecell populationVSAvoidcell phenotype
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent changes the chemical composition parameters of the culture medium by replacing serum-based media with a defined serum-free medium containing specific growth factors (bFGF, TGF-beta3) and supplements (insulin, transferrin, selenium). This parameter change maintains keratocyte phenotype while enabling cell expansion, resolving the contradiction between quantity increase and phenotype preservation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces specific growth factors and signaling molecules as intermediaries to mediate between the need for cell proliferation and the need to maintain keratocyte differentiation state. These intermediaries (bFGF for proliferation, TGF-beta3 for differentiation maintenance) enable simultaneous achievement of both goals without direct conflict.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Strength

If traditional scaffold materials are used for corneal tissue engineering, then structural support is provided, but the scaffolds fail to mimic native corneal stroma's optical properties and organized collagen structure

Engineering Contradiction:
Improvestructural supportVSAvoidcollagen organization
Core Design Contradiction:
StrengthVSManufacturing precision

Solution Approach 1:

The patent uses composite materials combining natural collagen (types I and V) with synthetic or semi-synthetic components to create a scaffold that simultaneously provides structural strength and mimics native corneal stroma's organized fiber architecture. The composite approach allows integration of mechanical support functions with optical transparency and collagen organization.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent transitions from two-dimensional cell culture to three-dimensional scaffold construction with layered architecture. Multiple layers of collagen fibers are assembled with specific orientations to replicate the nanoscale organization of native corneal stroma, adding dimensional complexity that enables both structural integrity and optical properties.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Reliability

If aligned collagen fibers are created to mimic native corneal stroma, then tissue transparency and mechanical strength improve, but the complexity of scaffold fabrication increases significantly

Engineering Contradiction:
Improvetissue transparencyVSAvoidscaffold fabrication
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent performs preliminary alignment of collagen fibers during scaffold fabrication before cell seeding. By pre-establishing the aligned fiber architecture and organizing the extracellular matrix structure in advance, the need for complex post-fabrication manipulation is reduced, and cells are guided to follow the pre-formed alignment cues, simplifying the overall process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs contact guidance principles where aligned collagen fibers and micro-patterned surfaces serve as self-organizing cues that automatically direct cell orientation and extracellular matrix deposition without requiring external intervention. The scaffold structure itself provides the instructions for cellular self-organization, reducing fabrication complexity.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The approach successfully generates a bioscaffold that replicates the native corneal stroma's structure and function, promoting tissue regeneration and repair by maintaining the alignment and organization of collagen fibers, thereby addressing the challenge of scar tissue formation.

Implementation Method 1

aligned fibers of a biocompatible, biodegradable polymeric composition that is optionally elastomeric, wherein more than one layer is present in the form of a plurality of layers, and the fibers of two or more layers are aligned at different angles

Methodology Applied
Scientific EffectElectrospinning: Electrohydrodynamics

Data Source

PatentUS10940239B2Bioengineered human corneal stromal tissue
Publication Date: 2021.03.09 UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
  • US10940239B2 patent drawing
  • US10940239B2 patent drawing
  • US10940239B2 patent drawing

AI summary

Provided herein is a method of making an aligned ECM scaffold useful in refractive correction of the eye and repair of the cornea. Methods of use of the scaffold as well as a scaffold construct are provided.